Ms. Ara Cho, Biomarker Research,Best Researcher Award

Ms. Ara Cho, at Seoul National University,South Korea

PROFILE

GOOLE scholar

🎓Early Academic Pursuits :

Ara Cho embarked on her academic journey at The Catholic University of Korea, where she pursued a Bachelor’s degree in Biology from the Department of Life Science and Environment. From March 2015 to February 2019, she dedicated herself to understanding the fundamental principles of biology, earning a B.S. in Biology with commendable academic performance. Her undergraduate years were marked by a growing interest in analytical chemistry and proteomics, which set the stage for her future research endeavors.

In September 2019, Ara Cho continued her academic pursuits at Seoul National University, enrolling in the Ph.D. program in the Department of Molecular Medicine and Biopharmaceutical Sciences. Her rigorous coursework and research in this program have been driven by a profound interest in mass spectrometry-based proteomics and translational bioinformatics. Maintaining an impressive GPA of 4.1/4.3, Ara has demonstrated exceptional academic prowess and a commitment to advancing scientific knowledge.

👩‍🔬Professional Endeavors :

Ara Cho’s professional journey is distinguished by a series of impactful research experiences and collaborations. She served as a research intern at the Graduate School of Convergence Science and Technology at Seoul National University from January 2018 to December 2018. This experience honed her skills in proteomics and data analysis, providing a solid foundation for her future research projects.

Subsequently, she continued as a research intern at the Department of Molecular Medicine and Biopharmaceutical Sciences at Seoul National University from March 2019 to August 2019. Her internship experiences allowed her to work on cutting-edge research projects, further deepening her expertise in proteomics and biomarker discovery.

From November 2022 to April 2023, Ara expanded her research horizons internationally as a researcher at the Fred Hutchinson Cancer Research Center in Seattle, United States. This position enabled her to collaborate with leading scientists and gain exposure to advanced research methodologies and technologies, significantly enriching her research portfolio.

🔬Contributions and Research Focus :

Ara Cho’s research is characterized by its focus on analytical chemistry, mass spectrometry-based proteomics, data analysis, machine learning, and translational bioinformatics. Her work aims to develop innovative biomarker panels and diagnostic strategies to improve disease prediction and treatment outcomes. Notable among her contributions are her publications in high-impact journals and her involvement in significant research projects.

Her research publications include:

  1. Proteomics Analysis of FFPE Tissue Sections: This study, published in Rapid Communications in Mass Spectrometry (2023), highlights Ara’s expertise in proteomics and her innovative use of isobaric-tag amplification for individual tissue sections.
  2. Multi-Biomarker Panel for Rheumatoid Arthritis: Published in Translational Research (2024), this research identifies biomarkers for predicting the response to Tocilizumab in rheumatoid arthritis patients, showcasing her translational bioinformatics skills.
  3. Refinement of Spectral Counting in Quantitative Proteomics: This work, published in Expert Review of Proteomics (2024), addresses limitations in spectral counting and enhances accuracy, reflecting Ara’s commitment to advancing proteomics methodologies.
  4. Neddylation of Insulin Receptor Substrate: Published in Cancer Gene Therapy (2024), this study explores the implications of insulin signaling in cancer cell migration, underlining her interdisciplinary research approach.
  5. TNF-α Modulation in Breast Cancer Cells: Featured in Cancer & Metabolism (2021), this research investigates the differential modulation of mitochondrial complex activity in breast cancer cells, emphasizing her contributions to cancer biology.

🏅Accolades and Recognition :

Ara Cho’s dedication and contributions to the field of proteomics have been recognized through various accolades and invitations to present her research at prestigious conferences. Noteworthy among her conference presentations are:

  1. Transformative Proteomics for Precision Medicine: An oral presentation at KHUPO Virtual Conference, Korea (September 2020), where she discussed the impact of proteomics on precision medicine.
  2. International Conference KSMCB 2020: A poster presentation at KSMCB Virtual Conference, Korea (October 2020), where she showcased her innovative research findings.
  3. 10th Asia-Oceania Human Proteome Organization Congress: An oral presentation in Busan, Korea (June 2021), highlighting her contributions to proteomics.
  4. 71st Conference on Mass Spectrometry and Allied Topics: A poster presentation in Texas, United States (June 2023), demonstrating her international research impact.

Impact and Influence 

Ara Cho’s research has had a profound impact on the field of proteomics and translational bioinformatics. Her work on biomarker discovery and diagnostic strategies has the potential to revolutionize personalized medicine, particularly in the context of autoimmune diseases and cancer. By integrating mass spectrometry with machine learning and bioinformatics, she has contributed to the development of predictive models and diagnostic tools that enhance treatment precision and patient outcomes.

🚀Legacy and Future Contributions :

Ara Cho’s legacy lies in her relentless pursuit of scientific excellence and her contributions to advancing proteomics research. Her innovative approaches and interdisciplinary research have paved the way for future discoveries in biomarker identification and disease diagnostics. As she continues her Ph.D. studies and beyond, Ara is poised to make further significant contributions to the scientific community, driving forward the fields of analytical chemistry, proteomics, and translational bioinformatics.

🎓Publication 

TNF-α differentially modulates subunit levels of respiratory electron transport complexes of ER/PR+ ve/− ve breast cancer cells to regulate mitochondrial complex activity and …

  • Authors   :Anjali Shinde, Hyeryeon Jung, Hayun Lee, Kritarth Singh, Milton Roy, Dhruv Gohel, Han Byeol Kim, Minal Mane, Hitesh Vasiyani, Fatema Currim, Yu Ri Seo, Seojin Yang, Ara Cho, Eugene C Yi, Rajesh Singh
  • Journal    :Cancer & Metabolism
  • Year         : 2021

Neddylation of insulin receptor substrate acts as a bona fide regulator of insulin signaling and its implications for cancer cell migration

    • Authors :Jun Bum Park, Geon Ho Moon, Ara Cho, Minji Kwon, Jong-Wan Park, Eugene C Yi, Haeryoung Kim, Junji Fukuda, Cheol Kwak, Young-Gyu Ko, Yang-Sook Chun
    • Journal   :Cancer Gene Therapy
    • Year       :

A Multi-Biomarker Panel for Predicting Tocilizumab Response in Rheumatoid Arthritis Patients

  • Authors  :, Ara Cho, Jinsung Ahn, Andrew Kim, Yun Jong Lee, Yeong Wook Song, Yoshiya Tanaka, C Yi Eugene
  • Journal    :Translational Research
  • Year         :  2024

Proteomics analysis of an individual formalin‐fixed paraffin‐embedded tissue section using isobaric‐tag amplification

  • Authors  :Ara Cho, Jinsung Ahn, Andrew Kim, Jeong Hyun Lee, Han Suk Ryu, Kristine M Kim, Eugene C Yi
  • Journal   :Rapid Communications in Mass Spectrometry
  • Year        :   2023

 

 

Ms. Ara Cho| Biomarker Research|Best Researcher Award

You May Also Like